| __timestamp | Exelixis, Inc. | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 189101000 | 85181000 |
| Thursday, January 1, 2015 | 96351000 | 135253000 |
| Friday, January 1, 2016 | 95967000 | 162297000 |
| Sunday, January 1, 2017 | 112171000 | 198442000 |
| Monday, January 1, 2018 | 182257000 | 226616000 |
| Tuesday, January 1, 2019 | 336964000 | 299726000 |
| Wednesday, January 1, 2020 | 547851000 | 335375000 |
| Friday, January 1, 2021 | 693716000 | 505748000 |
| Saturday, January 1, 2022 | 891813000 | 590453000 |
| Sunday, January 1, 2023 | 1044071000 | 849658000 |
| Monday, January 1, 2024 | 910408000 |
Unveiling the hidden dimensions of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Exelixis, Inc. and Jazz Pharmaceuticals plc have been at the forefront of this race. Since 2014, Exelixis has consistently increased its R&D investment, culminating in a staggering 450% growth by 2023. Jazz Pharmaceuticals, while also increasing its R&D budget, has seen a more modest growth of approximately 300% over the same period.
Exelixis's commitment to innovation is evident, with its R&D spending peaking at over $1 billion in 2023, surpassing Jazz's $850 million. This trend highlights Exelixis's aggressive strategy to lead in drug development. As these companies continue to invest heavily in R&D, the pharmaceutical landscape is set for exciting advancements.
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Exelixis, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Exelixis, Inc.
Research and Development Investment: Insmed Incorporated vs Exelixis, Inc.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
R&D Insights: How Sarepta Therapeutics, Inc. and Exelixis, Inc. Allocate Funds
Exelixis, Inc. vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Exelixis, Inc. vs Wave Life Sciences Ltd.
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
R&D Spending Showdown: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG